Back to Search
Start Over
Supplementary Figure 3 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 235KB, Activity of AZD9291 and metabolites against rare EGFR mutations using cellular phosphorylation assays.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....aae9b7c4ff971c9197748ea7ba30b12d
- Full Text :
- https://doi.org/10.1158/2159-8290.22532204